Shijiazhuang Yiling Pharmaceutical Co., Ltd. was founded by Wu Yiling, an academician of China Academy of Engineering. Under his leadership, Yiling Pharmaceutical has always adhered to the development strategy of scientific and technological innovation with science and technology as the guide and market as the leading factor, established a unique operation mode of "theory-clinic-scientific research-industry-teaching" and established an innovative technology system of new drug research and development oriented to the theoretical innovation of collateral diseases in traditional Chinese medicine.
Development of Yiling Pharmaceutical Industry
Yiling Pharmaceutical promoted the industrialization of traditional Chinese medicine with the innovation of collateral disease theory, applied modern high technology to research and develop scientific and technological traditional Chinese medicine, western medicine and biological medicine, and researched and developed more than one national patented new drug 10, and won the first prize of national scientific and technological progress 1 0, four second prizes of national scientific and technological progress, two prizes of national technological invention 1 0, and more than 30 provincial and ministerial-level scientific and technological awards.
Yiling Pharmaceutical has a Chinese medicine production line certified by the national GMP and a chemical preparation production workshop certified by the European Union. The production bases built by the company in Shijiazhuang, Daxing, Miyun and other places in Hebei ensure the supply of products, introduce advanced equipment and pharmaceutical technology at home and abroad, and build a total quality control system in line with international standards.